14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $143.51 $159.34 Tuesday, 23rd Apr 2024 ALNY stock ended at $146.07. This is 0.192% more than the trading day before Monday, 22nd Apr 2024. During the day the stock fluctuated 3.20% from a day low at $145.61 to a day high of $150.27.
90 days $143.51 $191.72
52 weeks $143.51 $218.88

Historical Alnylam Pharmaceuticals prices

Date Open High Low Close Volume
Aug 18, 2020 $140.35 $140.94 $138.83 $139.92 298 883
Aug 17, 2020 $137.79 $143.60 $137.00 $140.70 470 494
Aug 14, 2020 $137.05 $137.83 $134.48 $136.14 209 092
Aug 13, 2020 $138.11 $141.40 $136.78 $137.43 310 829
Aug 12, 2020 $136.32 $139.40 $135.02 $136.69 391 563
Aug 11, 2020 $136.66 $139.96 $133.40 $136.61 469 281
Aug 10, 2020 $143.50 $143.74 $137.22 $138.57 533 478
Aug 07, 2020 $145.26 $147.08 $142.18 $143.53 384 300
Aug 06, 2020 $148.64 $149.21 $141.50 $144.12 703 783
Aug 05, 2020 $153.13 $153.94 $146.77 $150.44 573 897
Aug 04, 2020 $152.32 $154.16 $150.56 $152.76 318 855
Aug 03, 2020 $146.79 $153.01 $145.58 $152.30 412 773
Jul 31, 2020 $151.34 $151.42 $143.61 $145.76 507 032
Jul 30, 2020 $148.52 $152.95 $148.52 $151.11 295 212
Jul 29, 2020 $155.67 $156.54 $150.37 $150.56 426 393
Jul 28, 2020 $157.06 $158.07 $153.54 $154.33 517 452
Jul 27, 2020 $155.68 $158.05 $151.54 $157.51 933 162
Jul 24, 2020 $152.41 $153.47 $148.59 $153.10 281 289
Jul 23, 2020 $159.07 $161.48 $154.13 $154.61 636 059
Jul 22, 2020 $158.42 $159.15 $155.55 $157.98 363 300
Jul 21, 2020 $165.02 $166.48 $157.34 $158.03 684 800
Jul 20, 2020 $164.67 $167.33 $160.17 $165.49 906 100
Jul 17, 2020 $157.36 $161.07 $155.94 $158.36 306 400
Jul 16, 2020 $157.54 $157.83 $153.99 $156.03 275 600
Jul 15, 2020 $157.49 $159.27 $155.73 $158.02 422 700
Click to get the best stock tips daily for free!

About Alnylam Pharmaceuticals

Alnylam Pharmaceuticals Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system (CNS)/ocular diseases. Its marketed products include ONPATTRO (patisiran), a lipid complex injection f... ALNY Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT